Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study-Reference-Cited by-同舟云学术

Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study

Published:2022-09-02 Issue:10 Volume:13 Page:1789-1809
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

de Lusignan Simon^ORCID,McGovern Andrew^ORCID,Hinton William^ORCID,Whyte Martin,Munro Neil^ORCID,Williams Emily D.,Marcu Afrodita^ORCID,Williams John,Ferreira Filipa^ORCID,Mount Julie^ORCID,Tripathy Manasa,Konstantara Emmanouela^ORCID,Field Benjamin C. T.^ORCID,Feher Michael^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-022-01306-z.pdf

Reference37 articles.

1. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in US diabetes care, 1999–2010. New Engl J Med. 2013;368(17):1613–24.

2. Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2018;137:137–48.

3. Stone MA, Khunti K, Charpentier G, et al. Quality of care of people with type 2 diabetes in eight European Countries: findings from the guideline adherence to enhance care (GUIDANCE) study. Diabetes Care. 2013;36(9):2628–38.